{"id":400426,"date":"2025-06-14T01:05:00","date_gmt":"2025-06-13T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=400426"},"modified":"2025-05-15T11:18:34","modified_gmt":"2025-05-15T09:18:34","slug":"dreamm-7-belamaf-mais-bortezomib-e-dexametasona-tem-um-desempenho-superior-ao-da-terapeutica-comparadora","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/dreamm-7-belamaf-mais-bortezomib-e-dexametasona-tem-um-desempenho-superior-ao-da-terapeutica-comparadora\/","title":{"rendered":"DREAMM-7: Belamaf mais bortezomib e dexametasona tem um desempenho superior ao da terap\u00eautica comparadora"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Em doentes com mieloma m\u00faltiplo, a doen\u00e7a \u00e9 frequentemente refract\u00e1ria \u00e0s terapias triplas ou qu\u00e1druplas de primeira linha. O resultado: ocorre uma reca\u00edda. Por conseguinte, s\u00e3o necess\u00e1rias combina\u00e7\u00f5es terap\u00eauticas eficazes de segunda linha que incluam novas abordagens de tratamento.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fdreamm-7-belamaf-mais-bortezomib-e-dexametasona-tem-um-desempenho-superior-ao-da-terapeutica-comparadora%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Em doentes com mieloma m\u00faltiplo, a doen\u00e7a \u00e9 frequentemente refract\u00e1ria \u00e0s terapias triplas ou qu\u00e1druplas de primeira linha. O resultado: ocorre uma reca\u00edda. Por conseguinte, s\u00e3o necess\u00e1rias combina\u00e7\u00f5es terap\u00eauticas eficazes&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fdreamm-7-belamaf-mais-bortezomib-e-dexametasona-tem-um-desempenho-superior-ao-da-terapeutica-comparadora%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":400429,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Mieloma m\u00faltiplo","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11521,11524,11365,11379],"tags":[60038,13892,29031,11958],"powerkit_post_featured":[],"class_list":["post-400426","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-formacao-continua","category-hematologia-pt-pt","category-oncologia-pt-pt","tag-combinacao-terapeutica","tag-mieloma-multiplo-pt-pt","tag-refractario","tag-terapia-de-segunda-linha","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-28 21:57:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":400424,"slug":"dreamm-7-belamaf-mas-bortezomib-y-dexametasona-supera-al-tratamiento-de-comparacion","post_title":"DREAMM-7: Belamaf m\u00e1s bortezomib y dexametasona supera al tratamiento de comparaci\u00f3n","href":"https:\/\/medizinonline.com\/es\/dreamm-7-belamaf-mas-bortezomib-y-dexametasona-supera-al-tratamiento-de-comparacion\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/400426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=400426"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/400426\/revisions"}],"predecessor-version":[{"id":400431,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/400426\/revisions\/400431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/400429"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=400426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=400426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=400426"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=400426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}